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Use of an Oriented Transmembrane Protein to Probe the Assembly of
a Supported Phospholipid Bilayer
Paul Brian Contino,* Carol A. Hasselbacher,* J. B. Alexander Ross,t and Yale Nemerson*t
Divisio of Moeular Medcine, * Departmt of Medcine and tDeparTen of Bixchmisty, Mount Sinai School of Medicine
of te City Unieri of New York, New York, New York 10029 USA
ABSTRACT Planar-supported phopholipid bilayers formed by te adsorpton of vesicles are increasingly used in the inves-
tigation of lipK-ependent reactis. We have studied the way in which these bilayers are forned with phopholipid vesicles
coaining the btranembrane protein Tssue Factor (TF). TF complexed with te senne protease, factor Vlla, is the primary
initiator of bklod coagulation by way of activation of the zymogen factor X. TF has been shown to orient randomly on the inner
and outer leaflets of vesicles. We used proteolytic digestion to produce vesicles in which the exracellular domain of TF is located
on the inner leaflet These vesicles show no cofactor activity for factor Vila as a result of the inability of the extacellular domain
of TF to bind Vila. After freeze/thawing, 50% of the cofactor activity was regained, indicating reorientation of the sequestered,
inner leaflet TF. Adsorpion of these vesicles to the inner surface of glass microcapillaries results in a continuous phospholpid
bilayer. The microcapillaries were perftsed with a solution of factors Vlla and X, and the effluent was monitored for factor Xa
production, a sensifive measure of the activity of the TF-Vlla complex. For coatings produced with the digested vesicles, minimal
TF-Vlla acfivity was observed, showing that the supported bilayer preserves the oientation of the leaflets in the vesicles, i.e.,
the outer leaflet of the vesicles forms the outer leaflet of the supported bilayer.
INTRODUCTION
Supported phospholipid bilayers have gained considerable
importance as model systems for the study of biological
membranes and lipid-dependent reactions. These bilayers
have been produced on a wide variety of surfaces such as
glass, quartz, silicon, mica, platinum, and chromium (Tamm
and McConnell, 1985; Helm et al., 1989; Tien and Salamon,
1990; Cuypers et al., 1983). Planar bilayers on solid surfaces
are frequenfly produced by the use of Langmuir-Blodgett
techniques (Agarwal, 1988), but have also been produced by
adsorption ofphospholipid vesicles to glass substrates (Watts
et al., 1984). These two methods have been shown to produce
bilayers that are physically and biologically indistinguish-
able from each other (Giesen et al., 1991). The latter method
has the advantages of allowing the incorporation of proteins
into the membranes and the use of surfaces of varied ge-
ometry, such as spherical beads (Bayerl and Bloom, 1990)
and cylindrical tubes (Gemmel et al., 1988). The physical
properties of these bilayers and their interaction with the
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support surface have been well studied, but the process by
which phospholipid vesicles assemble to form a continuous
supported bilayer is not well understood.
In forming a continuous supported bilayer, it is unknown
whether a vesicle retains a unique or a randomly deposited
orientation. We have used the orientation of a transmem-
brane protein to probe the assembly of a supported phos-
pholipid bilayer. The protein used in these studies is Tissue
Factor (TF), a glycoprotein consisting of an extraceliular
domain (residues 1-219), a single transmembrane domain
(residues 220-242), and a cytoplasmic domain (residues
243-263). After tissue damage, the binding of factor VIIa,
a serine protease, to TF produces a proteolytic complex that
is the primary initiator of blood coagulation (Nemerson,
1988). This complex activates factorX toXa The production
of Xa was used as a sensitive measure of TF activity. Upon
incorporation into phospholipid vesicles, TF was shown to
orient randomly on the inner and outer leaflets (Bach et al.,
1986). Proteolytic digestion of TF on the outer leaflet pro-
duced vesicles that were inert as a cofactor for the enzyme
VIIa. Upon randomization of the vesicles by repeated freez-
ing and thawing, the activity of the TF located on the inside
can be regained (see Fig. 1). We used these vesicles to char-
acterize the assembly of supported bilayers on the inner sur-
face of glass microcapillary tubes. The data in this paper
indicate that assembly of the bilayer occurs with a specific
orientation such that the outer leaflet of the vesicles forms the
outer leaflet of the supported bilayer.
MATERIALS AND METHODS
1,2-dioleoyl-sn-glycero-3-phosphatidylserine (DOPS) and 1,2-dioleoyl-sn-
glycero-3-hosphatidylholine (DOPC) were pumhasedfm Avanti Polar
Lipids, Inc (Alabaster, AL) and used without further prication -octyl-
glucopyranoside (13OG) was pwched from Calbiochem (La Jolla, CA).
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Human coagulation factorVIawas purchased from Novo NordiskA/S 2880
(Hilleroed, Denmark), and human factor X was purified as previously de-
scribed (Miletich et al, 1991). Recombinant human Tissue Factor (TF) in
IIOG was a generous gift from Dr. Gordon Vehar, Genentech, Inc. (South
San Francisco, CA). Diisopropyl-fluorophosphate (DFP) and Subtilisin
(Protease Type XXIV) were purchased from Sigma Chemical Co. (St. Louis,
MO). "C-DOPC was purchased from Amersham (Arington Heights, IL).
Aquasol-2 scintillation cocktail was purchased from Dupont-NEN Research
Products (Boston, MA). The chromogenic substrate for factor Xa; Ile-Pro-
Arg-p-nitoaniline (IPR-pNA) was synthesized by our laboratory. 3H-TF
was prepared by the reaction of TF with succinimidyl [2,3-3H] propionate
as per the manufcuer instcions (Dupont-NEN Research Products).
Specific activity of 3H-TF was 4.3 x 106 cpm/jlg.
Reconstitution of TF into phospholipW vesicles
DOPS and DOPC in CHC13 were combined to yeld a molar ratio of 30%
DOPS and 70% DOPC (using manufacturers weights) and dried under N2
for2 h onto the walls ofa borosilic glass tube. The lipids were then placed
in vacuo overnight to ensure complete drying. A solution of 375 mM POG
in HEPES-buffered saline (HBS) (0.01 M HEPES; 0.14 M NaCI; 0.01%
NaN3, pH 7.5) ('1 ml) was added to the dried lipids to yield a final lipid
concentration of 25 mM. TF was added to give the desired molar ratio of
protein-to-lipid (typically 1/100,000). Tracer amounts of 14C-DOPC and
3H-TF were added for precise quantification of protein and lipid concen-
trations in the final material. The preparation was gently vortexed at room
temperature until the lipids were solubilized. After completely dissolving
the lipids, an aiquot was taken for liquid scintillation countming (ISC) and
the remaining solution transferred to dialysis tubing (12,000-14,000 mo-
lecular weight cutoff, SpectroPor). The preparati was dialyzed against 3
X 1 1 of HBS for 72 h, with buffer changes every 24 h. After dialysis, an
aliquot was again taken for [SC and the remaning soluion was applied to
a 1.0 x 60 cm Sepharose CL-2B (Pharmacia, Piscataway, NJ) column
equilibrated with HBS. Column fractions were collected, and the elution
profile was obtained by light scattering at 280 mm. The elution peak was
pooled, and the lpid and protein concentration were determined radio-
metrically by comparison with the starting material. Veside pparations
were stored under N2 and refiigerated when not in use. Vesicles without TF
were prepared as descnbed above with the omission of protein and protein
tracer.
Protelytic digestion of tissue factor in vesicles
A sample of TF:DOPS:DOPC vesicles was mixed with DOPS:DOPC
vesicles to a TF concentrtion of 10 nM (lipid was maintained at 2 mM).
This sample was freze/thawed before use to assme fully randomized
vesicles. Freeze/thawing consisted of five cycles of freezing in a mixture of
acetone/dry ice and thawing in a water bath at 3rC. Concentrated protease
solutions were made just before use and kept on ice (15 mg of subtilisin to
0.5 ml HBS). Digestions were started by addition of protease (30 pi) to a
solution of TF vesicles (270 ;1 of TF:DOPS:DOPC (30:70) and incubated
at 37°C for 3 h The protease was then inactivated by the addition of 1 1
of DFP (2.5 M DFP in 2-propanol) for 1 h at 37°C. A control sample was
treated identically except for the addition of an equivalent amount of buffer
in place of the protease. The digested sample was then divided equally, and
one portion was freeze/thawed.
Tissue factor activity assays
Static assays
An automated robotic instrument has been developed by our laboratory to
perform kinetic assays ofTFactivity. TF samples were added to Eppendorf
tubes containing factor VIIa (10 nM) and X (250 nM) in HEPES-buffered
saline with 1 mg/ml bovine serum albumin (HBS-BSA) at 37°C. Fnal TF
concentrations were in the range of 1-1OpNt Theraton was initiatedwith
the addition of Ca2+ (5 mM). Aliquots were taken at timed intervals and
diluted into the wells of EIISA plates containing 125 JA of 50 mM EDTA
and 0.5 mg/ml BSA, pH 7.5, which quenched the reaction. Factor Xa con-
centatin were quantified by the addition of chromogenic substrate, IPR-
pNA, to a final concentration of 1.5 mMN lbe absorbance at 405 nm was
measured for 10 min at 37°C using a kinetic ELISA plate reader (TMax,
Molecular Devices, Menlo Park, CA) The formation of factor Xa in time
was fit by linear regression and used as the measure of TF activity.
Contnuous flow reactor assays
The instumental setup for the automated flow reactor system was as de-
scnrbed previously, (Contino et al, 1991). Cleaned microcapillary tubes
(027 mm inner diameter x 128 mm) were filled with the a iate TF-
phospholipid vesicles at room temperature and icubated for 20 min For
tubes coated with control vesices, the TF surface density was -13 fmol/
cm2. Tbereafter, the tbes wem flushed with HBS-BSA for 8 min at a wall
shear rate of 3000s- . The coated tubes were then perfused with a reaction
mixtur containing factors VIIa (10 nM), X (600 nM), and Ca2+ (5 mM) in
HBS-BSA at a wall shear rate of 1600 s-I at 3rC. The perfusate from
individual tubes was collected at timed intervals Into the wells of ELISA
plates contaiing 75 p1 of 50mM EDTA and 0.5 mg/ml BSA, pH 7.5. The
plates were assayed as descnibed above for factor Xa productin. The Xa
productio curve was integrated over the full time course of24 minand used
as the measure of TF activity.
RESULTS AND DISCUSSION
Proteolytic digestion and freeze/thawing of TF vesicles was
used to produce three types of vesicles: control, which have
TF equally distributed on the inner and outer leaflets; digest,
TF only on the inner leaflet; and Digest Freeze/Thaw, which
are TF-digested vesicles that have been randomized by the
process of freeze/thawing (see Fig. 1). Static assays for TF
activity show that proteolytic digestion of the outer leaflet
TF is complete. Upon freeze/thawing, TF is randomized on
the inner and outer leaflets of the vesicle (see Table 1). The
regained activity after freeze/thawing demonstrates that the
digestion has no effect on TFon the inner leaflet. To deduce
the orientation of vesicle deposition in the formation of a
supported bilayer, we used these three kinds ofvesicles in the
continuous flow reactor and monitored TF activity.
We can envision three ways in which a vesicle is adsorbed
at the support surface. One, the outer leaflet is adsorbed to
the surface preferentially exposing the inner leaflet. Two, the
adsorbed vesicle breaks open at its contact with the support
surface, and the inner leaflet is adsorbed to the surface pref-
erentially exposing the outer leaflet. Three, the vesicle is
adsorbed in a random fashion. After digestion of the extra-
cellular domain of TFon the outer leaflet, oriented deposition
of these vesicles should result in supported bilayers with
either 100l% or no activity compared with the control (see
Fig. 2). Random deposition would result in an intermediate
activity.
Table 1 demonstrates that TF activity in bilayers formed
from digested vesicles is less than 7% of the control activity,
which suggests a predominant orientation to the vesicle
deposition on the glass surface. As expected, the Digest
Freeze/haw presented 50%o of the control activity, which
mirrors the results found for vesicles in the static assays.
Fig. 3 shows the typical profiles generated in the continuous
flow reactor.
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FIGURE 1 S tc reprstation of Tissue Factor. phospholipid
vesices, The CONTIROL vesides are shown with TF randomly distriuted
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leaflet TF moeckles are diested, leaving the iTF m s se-
questred within the vesicle (DIGESI} By repeated freee/tawing ofthese
vesices, the orintation of the r TF moeules can be ized
(DIGEST Freez1Thaw) The TF:VIla acivity of the DIGEST and DIGEST
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cm
E
0Q
E
0x
MODEL 1
4,
DIGESTED
VESCLE
k N MODEL2
2tw=~ w
Sw~~a
ACTIVE NACTVE
BILAYER I I
AWW SUfACE
FIGURE 2 Schematic representation of vesicle defomnation am! adsrp-
tion to the support surface. Model 1 shows the vesicde dqeosition with the
ot fl orited towards the surface. Model 2 shows the ;adstin of
the imner kaflet The TF of the digested vesces by model 1 will be 100%
active, whereas by model 2 all aivhy will be absent
TABLE 1 Compwlson of is factso aciviy in sIc amd
cotinoue flow mays
Factor Xa p
Static* Fbo%
% of % of
pm control PMOl control
Control 59.0 13 100 130.9 1.1 100
Digest 02±0.1 0.4 0.1 9.1± 10 6.9 ± 0.7
Digest 285 ±0.8 48.2 05 60.4 3.7 46.1 ±27
fteezthaw
Data are presented as the mean ± C.V. of four expements.
* Static: Samples of the control, digest, and digest fieeze/thaw vesicle
diluted to 10 pM TF were icubated with 10 nM factor VIIa and 250 nM
fator X m HBS-BSA. The reacion was initiated with 5 mM Ca2+. Factor
Xa poduction was measured in timed aliquots.
$ Flow. Glass aill were filed with the indited vesicle soluibon
and then flushed with HBS-BSA. The coated tubes were perfused with a
solution containing 10 nM fator VIla, 600 nM factor X, and S mM Ca2+
in HBS-BSA at a waIl shear rate of 1600 s-' at 37'C. The perfusate was
collected into the wells of an ELISA plate filed with an EDTA solution.
The datapted are the intgao of the Xa pr on arves over the
full time corse (see FR 3)
Time (min)
FIGURE 3 Xa producti carves for the three types of vesickes in the
continuous flow reacor. The gjass i i tubes were filled with the
indicated vesicle epar for 20 min at room temperature. The tubes
were flushed with HBS-BSA for 8 min at a wall shear rate of 3000 s-'. The
reactio was initiated by perfusion of the tube with a sohlion conta g 600
nM factor X, 10 nM factor Vila, 5 mM Ca2+ at a wall shear rate of 1600
s-' at 37C Each curve is typical of four separate expeiments.
The process by which a phospholipid bilayer is deposited
on a solid surface is not well understood. It involves transport
of the vesicles towards and adherence to the surface, defor-
mation and rupture of the vesicles, straightening of the phos-
pholipid surfaces, and fusion of these surfawes. The adher-
ence of negatively charged DOPS-containing vesicles to a
negatively charged glass surface requires the presence of
counter ions. Interestingly, the deposition of phospholipid
stops at a single bilayer (Cuypers et al., 1983; Giesen et al.,
1991; Gemmel et al., 1988; Contino et al., 1991; Schoen
et al., 1990), which is separated from the support surface by
a 1.7 + 0.5 nm water layer (Bayerl and Bloom, 1990; Andree
1115Cof etal.
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et al., 1992). Apparently, phospholipid vesicles do not adhere
to preformed bilayers. The question we address here is
whether there is a sidedness to the deposition process. Kalb
and co-workers (Kalb et al., 1992; Kalb and Tamm, 1992)
have used vesicle fusion to supported monolayers to produce
supported bilayers. They have proposed a mechanism that
results in both the inner and outer leaflets of the vesicle form-
ing the second monolayer. Tlhis situation is significantly dif-
ferent from the one we use, in that vesicle fusion to a pre-
formed monolayer is driven by hydrophobic interactions,
whereas fusion to a glass surface is largely hydrophilic. We
have shown that the supported bilayers formed on glass sur-
faces by phospholipid vesicles with the extracellular domain
of TF located only on the inner leaflet have little cofactor
activity for VIa. We have also shown that control vesicles
with the extraceilular domain located on both surfaces main-
tain cofactor activity for VIla. Together, these results indi-
cate that the vesicle deposition has a predominant orientation
in which greater than 93% of the vesicles are directed toward
the inner leaflet of the sport surfce. Moreover, the design of
the experiment demonsrates that the protem plays no role in es-
tablishing the orintation of the spported phospholipid bilayer.
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